Nanotechnology can be employed to develop novel antiviral agents that can inhibit the replication of viruses or enhance the immune response. These nanomaterials can be engineered to interact specifically with viral components, potentially offering higher efficacy and reduced side effects compared to conventional antiviral drugs.